Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$3.54 - $6.84 $24,252 - $46,860
6,851 Added 23.31%
36,241 $223,000
Q4 2023

Feb 13, 2024

SELL
$4.16 - $6.87 $495 - $817
-119 Reduced 0.4%
29,390 $148,000
Q3 2023

Nov 13, 2023

BUY
$3.56 - $5.75 $3,738 - $6,037
1,050 Added 3.69%
29,509 $169,000
Q2 2023

Aug 04, 2023

BUY
$3.51 - $4.69 $99,891 - $133,472
28,459 New
28,459 $103,000
Q2 2022

Aug 12, 2022

SELL
$1.23 - $3.25 $27,034 - $71,431
-21,979 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$2.0 - $3.28 $3,094 - $5,074
-1,547 Reduced 6.58%
21,979 $44,000
Q4 2021

Feb 11, 2022

BUY
$3.14 - $5.15 $8,223 - $13,487
2,619 Added 12.53%
23,526 $74,000
Q3 2021

Nov 12, 2021

SELL
$4.89 - $7.12 $552 - $804
-113 Reduced 0.54%
20,907 $102,000
Q2 2021

Aug 13, 2021

BUY
$5.65 - $7.47 $10,825 - $14,312
1,916 Added 10.03%
21,020 $140,000
Q1 2021

May 07, 2021

BUY
$5.61 - $12.01 $286 - $612
51 Added 0.27%
19,104 $107,000
Q4 2020

Feb 12, 2021

BUY
$6.99 - $9.26 $30,790 - $40,790
4,405 Added 30.07%
19,053 $150,000
Q3 2020

Nov 04, 2020

BUY
$8.49 - $19.54 $17,744 - $40,838
2,090 Added 16.64%
14,648 $124,000
Q2 2020

Aug 12, 2020

SELL
$7.44 - $11.29 $5,743 - $8,715
-772 Reduced 5.79%
12,558 $131,000
Q1 2020

May 04, 2020

SELL
$6.94 - $14.22 $5,343 - $10,949
-770 Reduced 5.46%
13,330 $125,000
Q4 2019

Feb 05, 2020

SELL
$7.99 - $37.6 $950 - $4,474
-119 Reduced 0.84%
14,100 $113,000
Q3 2019

Nov 08, 2019

SELL
$19.17 - $27.4 $1,897 - $2,712
-99 Reduced 0.69%
14,219 $292,000
Q2 2019

Aug 23, 2019

BUY
$22.93 - $42.84 $328,311 - $613,383
14,318 New
14,318 $374,000
Q2 2019

Aug 13, 2019

SELL
$22.93 - $42.84 $295,544 - $552,164
-12,889 Closed
0 $0
Q1 2019

May 06, 2019

BUY
$32.69 - $47.91 $41,973 - $61,516
1,284 Added 11.06%
12,889 $501,000
Q4 2018

Feb 13, 2019

SELL
$37.1 - $50.11 $3,227 - $4,359
-87 Reduced 0.74%
11,605 $488,000
Q3 2018

Nov 09, 2018

BUY
$36.35 - $55.2 $7,633 - $11,592
210 Added 1.83%
11,692 $585,000
Q2 2018

Aug 08, 2018

BUY
$33.85 - $50.65 $131,541 - $196,825
3,886 Added 51.16%
11,482 $439,000
Q1 2018

May 07, 2018

SELL
$32.45 - $54.7 $13,207 - $22,262
-407 Reduced 5.09%
7,596 $305,000
Q4 2017

Feb 09, 2018

BUY
$21.8 - $39.35 $806 - $1,455
37 Added 0.46%
8,003 $281,000
Q3 2017

Nov 09, 2017

BUY
$16.4 - $25.05 $130,642 - $199,548
7,966
7,966 $173,000

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.16B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.